Table 3.
Characteristic | Good QoL | OR | 95% CI | p | AOR | 95% CI | p | |
---|---|---|---|---|---|---|---|---|
N | % | |||||||
Socio-demographic | ||||||||
Gender | ||||||||
Male | 89 | 37.4 | 1.0 | 1.0 | ||||
Female | 100 | 47.6 | 1.52 | 1.04–2.22 | 0.03 | 0.61 | 0.33–1.13 | 0.1 |
Age | ||||||||
≥30 years | 23 | 28.7 | 1.0 | 1.0 | ||||
<30 years | 166 | 45.0 | 2.03 | 1.20–3.43 | 0.009 | 1.55 | 0.74–3.25 | 0.2 |
Place of living | ||||||||
Ida-Viru county, north-eastern Estonia | 105 | 35.5 | 1.0 | 1.0 | ||||
Capital city, Tallinn | 74 | 56.5 | 2.4 | 1.56–3.57 | 0.0001 | 1.08 | 0.62–1.88 | 0.8 |
Ethnicity | ||||||||
Russian | 157 | 42.3 | 1.0 | |||||
Estonian | 24 | 55.8 | 1.7 | 0.91–3.25 | 0.09 | |||
Education | ||||||||
≤9 years | 69 | 38.3 | 1.0 | |||||
>9 years | 120 | 44.9 | 1.31 | 0.89–1.93 | 0.2 | |||
Occupation | ||||||||
Unemployed | 123 | 38.2 | 1.0 | 1.0 | ||||
Employed and/or studying | 65 | 52.0 | 3.13 | 2.04–4.76 | <0.0001 | 2.27 | 1.18–4.38 | 0.01 |
Partnership | ||||||||
Other | 129 | 38.6 | 1.0 | 1.0 | ||||
Legally married | 58 | 54.7 | 1.92 | 1.24–2.99 | 0.004 | 1.26 | 0.66–2.41 | 0.5 |
HIV disease related | ||||||||
HIV transmission category (self report) | ||||||||
Injecting drug use | 89 | 37.7 | 1.0 | 1.0 | ||||
Sexual transmission | 86 | 53.4 | 1.89 | 1.27–2.86 | 0.002 | 1.37 | 0.73–2.59 | 0.3 |
Time of HIV diagnosis | ||||||||
≥12 months ago | 99 | 40.6 | 1.0 | 1.0 | ||||
<12 months ago | 47 | 54.0 | 1.79 | 1.1–2.86 | 0.02 | 1.2 | 0.60–2.45 | 0.6 |
Stage of HIV-infection | ||||||||
Early HIV disease/AIDS | 49 | 28.2 | 1.0 | 1.0 | ||||
No symptoms | 136 | 50.9 | 2.65 | 1.76–3.98 | <0.0001 | 2.31 | 1.24–4.29 | 0.008 |
CD4 count | ||||||||
<300 cells/mm3 | 32 | 31.7 | 1 | 1.0 | ||||
≥300 cells/mm3 | 128 | 53.6 | 2.49 | 1.52–4.06 | 0.0003 | 1.72 | 0.91–3.26 | 0.09 |
Current ARV treatment | ||||||||
No | 136 | 40.2 | 1.0 | |||||
Yes | 52 | 48.1 | 1.37 | 0.89–2.13 | 0.1 | |||
Co-infections | ||||||||
Tuberculosis | ||||||||
Yes | 4 | 40.0 | 1 | |||||
No | 184 | 42.1 | 1.09 | 0.3–3.92 | 0.9 | |||
Hepatitis B and/or C co-infection | ||||||||
Yes | 106 | 39.8 | 1 | |||||
No | 83 | 45.6 | 1.27 | 0.86–1.85 | 0.2 |